Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NDV-3A Vaccine for S. Aureus Colonization in Military Recruits
NCT03455309Phase 2Completed
- Sponsor
- NovaDigm Therapeutics
- Start
- Jan 2018
- Primary completion
- Jul 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of NDV-3 vaccine in Staphylococcus aureus infection, sponsored by NovaDigm Therapeutics. Started Jan 2018; status: completed.
02
Drugs
NDV-3 vaccine
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on NCT03455309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03455309.